Clinical Trials Logo

Clinical Trial Summary

This randomized, prospective study evaluates incision closure, post-surgical wound complications, dressing changes, incision/scar appearance, pain associated with dressing changes, and patient satisfaction rates of an activated carbon dressing versus two commercially available wound dressings.


Clinical Trial Description

Postoperative incision complications and surgical site infections are risks for patients undergoing surgery. While most surgical incisions heal without complications, postoperative complications, such as erythema, blistering, maceration, scarring, necrosis, and infection, interfere with the normal healing process. Preventing such complications must be a priority, as they may contribute to longer recovery times, as well as increased hospital stays, costs, and morbidity.

Ideally, surgical incision dressings should exhibit the following characteristics:

- promote a moist environment;

- be absorbent, but transparent so fluid accumulation and other complications may be observed;

- be permeable;

- be low adherent to facilitate removal from skin;

- act as a complete barrier to bacteria and water, but not to moisture vapor; and

- feature some flexibility to avoid restricted limb movement and postoperative edema in the incision area [Chen et al; Collins].

However, despite advances in wound dressing designs, there is no consensus regarding the ideal surgical incision dressing. One emerging dressing modality exhibits these key characteristics. This novel activated carbon cloth dressing is low-adherent, comprised of 100% pure activated carbon and also conforms to body contours to maintain contact with the incision surface.

This randomized, prospective clinical trial will compare this activated carbon cloth dressing to two other commercially-available wound dressings, including a non-adherent antimicrobial alginate dressing with silver and a non-adhering knitted cellulose acetate mesh dressing soaked in Povidone-iodine. The primary endpoint is incision coaptation/closure. Secondary endpoints include incision/scar appearance, such as inflammation and edema, odor, pain, patient satisfaction, and number of dressing changes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04038671
Study type Interventional
Source Liden, Brock, DPM
Contact
Status Withdrawn
Phase N/A
Start date January 7, 2019
Completion date February 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04407364 - MPM Medical CoMatryx Surgical Bovine Collagen Study
Active, not recruiting NCT06190015 - Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars Phase 4
Completed NCT05716490 - Optimizing Closed Incision Negative Pressure Wound Therapy in Emergency Laparotomy N/A